Search research articles
Contact Us
Filters
Showing results (91-100 of 161) with videos related to
Page
of 17
Sort By:
The American Journal of Medicine
|
September 11, 1975
Leukemic reticuloendotheliosis. A study of the origin of the malignant cell
G W King, P E Hurtubise, A L Sagone, et al.
Cellular Immunology
|
May 1, 1976
Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor
M S O'Dorisio, J A Neidhart, F B Daniel, et al.
Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission
|
September 15, 1998
Chimeric antibodies with specificity for tumor antigens: demonstration of in situ localization to tumors after antibody therapy
M N Saleh, A B Tilden, R F Meredith, et al.
Cellular Immunology
|
April 1, 1973
The effect of transfer factor therapy on tumor immunity in alveolar soft part sarcoma
A F LoBuglio, J A Neidhart, R W Hilberg, et al.
Hybridoma
|
July 1, 1986
Phase I clinical trial of CO17-1A monoclonal antibody
A F Lobuglio, M Saleh, L Peterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine
R M Conry, K O Allen, S Lee, et al.
Journal of Clinical Immunology
|
March 1, 1992
Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody
M B Khazaeli, M N Saleh, T Liu, et al.
Human Antibodies and Hybridomas
|
October 1, 1993
An animal model to predict the immunogenicity of murine V regions in humans
A M Cartner, R M Conry, A Safavy, et al.
Archives of Dermatology
|
June 1, 1986
Etretinate therapy and immune activities
S Kang, C N Ellis, R C Grekin, et al.
Journal of the National Cancer Institute
|
August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspects
A F LoBuglio, M N Saleh, J Lee, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 161) with videos related to
Sort By:
Page
of 17
The American Journal of Medicine
|
September 11, 1975
Leukemic reticuloendotheliosis. A study of the origin of the malignant cell
G W King, P E Hurtubise, A L Sagone, et al.
Cellular Immunology
|
May 1, 1976
Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor
M S O'Dorisio, J A Neidhart, F B Daniel, et al.
Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission
|
September 15, 1998
Chimeric antibodies with specificity for tumor antigens: demonstration of in situ localization to tumors after antibody therapy
M N Saleh, A B Tilden, R F Meredith, et al.
Cellular Immunology
|
April 1, 1973
The effect of transfer factor therapy on tumor immunity in alveolar soft part sarcoma
A F LoBuglio, J A Neidhart, R W Hilberg, et al.
Hybridoma
|
July 1, 1986
Phase I clinical trial of CO17-1A monoclonal antibody
A F Lobuglio, M Saleh, L Peterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine
R M Conry, K O Allen, S Lee, et al.
Journal of Clinical Immunology
|
March 1, 1992
Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody
M B Khazaeli, M N Saleh, T Liu, et al.
Human Antibodies and Hybridomas
|
October 1, 1993
An animal model to predict the immunogenicity of murine V regions in humans
A M Cartner, R M Conry, A Safavy, et al.
Archives of Dermatology
|
June 1, 1986
Etretinate therapy and immune activities
S Kang, C N Ellis, R C Grekin, et al.
Journal of the National Cancer Institute
|
August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspects
A F LoBuglio, M N Saleh, J Lee, et al.
Page
of 17